PATENT REGISTER | |||||||||||||||||||||||||||||||||||
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2003/014 2005/001 2014/050 2014/053 | |||||||||||||||||||||||||||||||||||
Status | Expired | Patent No. | 0720599 | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Application No. | 94928563.9 | Date of Filing | 14/09/1994 | ||||||||||||||||||||||||||||||||
Date Grant Published | 19/05/1999 | Application Published | 21/03/1995 | ||||||||||||||||||||||||||||||||
Title of Invention | HYDROXY-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS | ||||||||||||||||||||||||||||||||||
Priority |
|
||||||||||||||||||||||||||||||||||
Inventors |
ROSENBLUM, Stuart, B. DUGAR, Sundeep BURNETT, Duane, A. CLADER, John, W. MCKITTRICK, Brian, A. |
||||||||||||||||||||||||||||||||||
Patent Granted to |
SCHERING CORPORATION 2000 Galloping Hill Road Kenilworth, NJ 07030 UNITED STATES OF AMERICA |
||||||||||||||||||||||||||||||||||
Current Proprietor |
Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway New Jersey 07065 UNITED STATES OF AMERICA |
||||||||||||||||||||||||||||||||||
Address for service |
TOMKINS & CO. 5 Dartmouth Road Dublin 6 IRELAND |
||||||||||||||||||||||||||||||||||
Renewal Fees |
|
||||||||||||||||||||||||||||||||||
Publication Language | English | ||||||||||||||||||||||||||||||||||
Translation Received Date | |||||||||||||||||||||||||||||||||||
06/11/2003 | Request for grant a Supplementary Protection Certificate, citing Patent number 0720599 as the relevent basic patent, in respect of the product Ezetimibe or a pharmaceutically acceptable salt thereof. filed on 30/10/2003. Reference number of request is 2003/014. | ||||||||||||||||||||||||||||||||||
27/01/2005 | Request for grant a Supplementary Protection Certificate, citing Patent number 0720599 as the relevent basic patent, in respect of the product Ezetimibe, or a pharmaceutically acceptable salt therof, in combination with a cholesterol biosynthesis inhibitor such as simvastatin. filed on 21/01/2005. Reference number of request is 2005/001. | ||||||||||||||||||||||||||||||||||
03/08/2005 | Supplementary Protection Certificate Number 2003/014, having an expiry date of 16/10/2017 granted on 03/08/2005. | ||||||||||||||||||||||||||||||||||
03/08/2005 | Supplementary Protection Certificate Number 2005/001, having an expiry date of 01/04/2019 granted on 03/08/2005. | ||||||||||||||||||||||||||||||||||
19/07/2012 | Change of name and address of proprietor from SCHERING CORPORATION, 2000 Galloping Hill Road, Kenilworth, NJ 07030, United States of America to Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States of America recorded on 12/07/12. | ||||||||||||||||||||||||||||||||||
15/09/2014 | Request for grant a Supplementary Protection Certificate, citing Patent number 0720599 as the relevant basic patent, in respect of the product Ezetimibe and rosuvastatin or pharmaceutically acceptable salts thereof, including rosuvastatin as a zinc salt filed on 11/09/2014. Reference number of request is 2014/050. | ||||||||||||||||||||||||||||||||||
17/09/2014 | Request for grant a Supplementary Protection Certificate, citing Patent number 0720599 as the relevant basic patent, in respect of the product ezetimibe and atorvastatin or pharmaceutically acceptable salts thereof, including atorvastatin as atorvastatin calcium trihydrate filed on 12/09/2014. Reference number of request is 2014/053. | ||||||||||||||||||||||||||||||||||
13/10/2014 | Patent expired on 13/09/2014. | ||||||||||||||||||||||||||||||||||
24/08/2015 | Application for an extension of the duration of Supplementary Protection Certificate No. 2003/014 filed on 22/07/2015. | ||||||||||||||||||||||||||||||||||
16/06/2016 | Application for an extension of the duration of Supplementary Protection Certificate No. 2003/014 granted on 16/06/2016. New expiry date of Supplementary Protection Certificate, as extended, is 16/04/2018. | ||||||||||||||||||||||||||||||||||
22/05/2017 | Request for grant of Supplementary Protection Certification No. 2014/050 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009 | ||||||||||||||||||||||||||||||||||
03/03/2021 | Supplementary Protection Certificate No. 2005/001 revoked by Order of the High Court dated 29 November 2019. |